Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
Mutoh, Michihiro
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice. [electronic resource] - Biological chemistry Apr 2006 - 381-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1431-6730
10.1515/BC.2006.051 doi
Age Factors
Animals
Benzamides--metabolism
Bezafibrate--administration & dosage
Cyclooxygenase 2--metabolism
Genes, APC
Humans
Hyperlipidemias--blood
Intestinal Polyps--metabolism
Lipoprotein Lipase--metabolism
Membrane Proteins--metabolism
Mice
Organophosphorus Compounds--metabolism
PPAR alpha--metabolism
PPAR gamma--metabolism
Pioglitazone
Thiazolidinediones--administration & dosage
Triglycerides--blood
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice. [electronic resource] - Biological chemistry Apr 2006 - 381-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1431-6730
10.1515/BC.2006.051 doi
Age Factors
Animals
Benzamides--metabolism
Bezafibrate--administration & dosage
Cyclooxygenase 2--metabolism
Genes, APC
Humans
Hyperlipidemias--blood
Intestinal Polyps--metabolism
Lipoprotein Lipase--metabolism
Membrane Proteins--metabolism
Mice
Organophosphorus Compounds--metabolism
PPAR alpha--metabolism
PPAR gamma--metabolism
Pioglitazone
Thiazolidinediones--administration & dosage
Triglycerides--blood